Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Leukemia, Myeloid, Acute 2Leukemia 2Uterine Cervical Neoplasms 1Stomatitis 1Neutropenia 1Neoplasms 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Drug-Related Side Effects and Adverse Reactions 1Blast Crisis 1

Interventions

Radiotherapy 9Cisplatin 9Paclitaxel 6Carboplatin 6Radiation 3Biopsy 3Bevacizumab 3balstilimab 2Topotecan 2Taxes 2Nivolumab 2Ipilimumab 2Gemcitabine 2Colposcopy 2Brachytherapy 2tislelizumab 1spartalizumab 1sitravatinib 1rucaparib 1pazopanib 1infigratinib 1fludarabine 1bemarituzumab 1atezolizumab 1aldesleukin 1Watchful Waiting 1Vinorelbine 1Vaginal Smears 1Ultrasonography 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Uterine Cervical Neoplasms × Amifostine × Clear all
NCT00137358 2013-01-24

Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer

University of Alabama at Birmingham

Phase 1 Withdrawn
Gynecologic

Uterine Cervical Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡